Product Information
BUPROPION HCL 75 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0928 per EA under NDC 62135072390. Its NADAC has been published 147 times since Dec 13, 2023.
FDA first approved this application on Aug 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Chartwell RX LLCNDC
62135072390
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206975FDA Approved
8/19/2016
TE Code
AB
On Market Since
8/19/2016
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL 75 MG TABLET has been published 147 times since Dec 13, 2023, and over the history we have for it it has declined 22.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0928 per EA |
|---|---|
| All-time high | $0.1260 (Jun 12, 2024) |
| All-time low | $0.0862 (Nov 20, 2024) |
| 52-week high | $0.0991 |
| 52-week low | $0.0928 |
| Median price | $0.1002 |
| Average price | $0.1031 |
| Largest weekly change | -20.2% (Nov 20, 2024) |
| Weeks tracked | 147 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bupropion Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoketone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUPROPION HCL 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL 75 MG TABLET, manufactured by Chartwell RX LLC, is $0.0928 per EA (NDC 62135072390), effective Sep 30, 2026.
How has the price of BUPROPION HCL 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL 75 MG TABLET has declined 22.5%. It has been tracked across 147 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL 75 MG TABLET?
Since Dec 13, 2023, the NADAC for BUPROPION HCL 75 MG TABLET has ranged from a low of $0.0862 (Nov 20, 2024) to a high of $0.1260 (Jun 12, 2024), with a median of $0.1002 per EA.
Are there cheaper alternatives to BUPROPION HCL 75 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL 75 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPROPION HCL 75 MG TABLET?
BUPROPION HCL 75 MG TABLET (NDC 62135072390) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.